A 14‑year‑old with severe eosinophilic asthma is being evalu…
A 14‑year‑old with severe eosinophilic asthma is being evaluated for initiation of a biologic medication. Which of the following is a key contraindication or precaution that must be assessed before starting therapy with a monoclonal antibody (e.g., mepolizumab, dupilumab)?
Read Details